Moderators: Joseph G Rogers, MD and Peter Hopkins, FRACP

Welcome and President's Message
Joseph G Rogers, MD, Duke University Health System, Durham, NC, USA

Program Panel Introduction
Peter Hopkins, FRACP, The Prince Charles Hospital, Brisbane, Australia

Featured Presentation: (154) Alpha 1 Antitrypsin Treatment during Human Ex Vivo Lung Perfusion Improves Lung Function by Protecting Lung Endothelium
Andrea Mariscal, MD, PhD, Toronto General Research Institute / University Health Network, Toronto, ON, Canada

Featured Discussant Q & A
Goran Dellgren, MD, PhD, Sahlgrenska University Hospital, Gothenburg, Sweden

Featured Presentation: (3) The Fontan VAD Physiology Project (FVPP)
Ari Michael Cedars, MD, Johns Hopkins University, Baltimore, MD, USA

Featured Discussant Q & A
Matthew Fenton, MB BS, BSc MRCPCH, Great Ormond Street Hospital, London, United Kingdom

MAID - Medical Assistance in Dying: Implications for Transplantation
James Downar, MDCM, MHSc, FRCPC, University of Ottawa, Ottawa, ON, Canada
Palliative Care focuses on improving quality of life and symptom control for people with incurable or life-threatening disease. In some countries patients can receive medical assistance in dying (MAID). This practice raises important ethical, moral and legal issues. Organ donation after circulatory determination of death (DCD) is a widely accepted practice nowadays. Although most people who receive MAID are ineligible to donate their organs, some countries allow this to take place for donors who are eligible. The combination of DCD and MAID raises additional legal and ethical concerns, which patients and clinicians need to be aware of. This presentation will give an overview of the current guidelines and principles in Canada.

Moderated Q & A
Pamela Combs, PhD, RN, University of Chicago, Chicago, IL, USA

Featured Presentation: (4) Artificial Intelligence for Early Prediction of Pulmonary Hypertension Using Electrocardiography
Kyung-Hee Kim, MD, PhD, Sejong General Hospital, Bucheon, South Korea

Featured Discussant Q & A
Paul Corris, MB FRCP, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
 

Continuing Education Information

Learning Objectives – at the conclusion of this session, attendees will be able to discuss:

• Palliative Care on improving quality of life and symptom control for people with incurable or life-threatening disease.
• Alpha 1 Antitrypsin Treatment during Human Ex Vivo Lung Perfusion Improves Lung Function by Protecting Lung Endothelium
• The Fontan VAD Physiology Project (FVPP)
• Artificial Intelligence for Early Prediction of Pulmonary Hypertension Using Electrocardiography
   

Target Audience – The target audience for the June Plenary Session includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.

Activity Designed to Change – This activity is designed to change knowledge, competence and performance.

Learning Attributes   Patient Care and Medical Knowledge

Disclosures – Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.

Disclaimer – The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.

Documenting CME Credits – The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf.